Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03265912 · ClinicalTrials.gov registry record
Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment
A clinical trial, sponsored by ElMindA.
- Completed
- Registry status
- 46
- Enrollment target
NCT03265912 is a clinical trial that has completed, run by ElMindA. The registered enrollment target is 46 participants.
The verdict
NCT03265912 has completed, sponsored by ElMindA.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
mTBI is widely recognized as a major public health concern in the United States and worldwide. mTBI diagnosis remains a clinical challenge as no single test can diagnose every concussion. Recent advances in EEG evoked response potential analysis have led to a novel technique for assessing brain network activation (BNA) patterns. This study purpose is to study this BNA technology in individuals who have sustained a concussion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2017-01-26 |
| Est. Completion | 2018-01-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03265912
The ClinicalTrials.gov registry entry for NCT03265912 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ElMindA, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03265912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03265912 about?
NCT03265912 is a clinical study titled "Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment". mTBI is widely recognized as a major public health concern in the United States and worldwide. mTBI diagnosis remains a clinical challenge as no single test can diagnose every concussion. Recent advances in EEG evoked response potential analysis have led to a novel technique for assessing brain netw...
What is the current status of trial NCT03265912?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2017-01-26. Estimated completion is 2018-01-16.
Who is sponsoring clinical trial NCT03265912?
This trial is sponsored by ElMindA, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.